APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Contract Sales Organization (CSO)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Contract Sales Organization (CSO) Market Outlook and Growth Opportunities 2026

16 January 2026204 pages

Choose your research edition.

Industry ResearchPharmaceutical Contract Sales Organization (CSO) Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Contract Sales Organization (CSO) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Contract Sales Organization (CSO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Contract Sales Organization (CSO) Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Contract Sales Organization (CSO) Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Pharmaceutical Contract Sales Organization (CSO) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Contract Sales Organization (CSO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Contract Sales Organization (CSO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Contract Sales Organization (CSO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Contract Sales Organization (CSO) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Contract Sales Organization (CSO) market include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, Ashfield Engage (Inizio), Amplity Health, Sinco Pharma, Syneos Health and EPS Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Contract Sales Organization (CSO) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Contract Sales Organization (CSO) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Contract Sales Organization (CSO) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Contract Sales Organization (CSO) market.

Pharmaceutical Contract Sales Organization (CSO) Segment by Company

China Medical System (CMS)

IQVIA

PHOENIX Group

EVERSANA

Ashfield Engage (Inizio)

Amplity Health

Sinco Pharma

Syneos Health

EPS Corporation

Uniphar Group

CMIC Group

SciClone Pharmaceuticals

China Pioneer Pharma

Promoveo Health

CSO Pharmitalia

GTS Solution

QFR Solutions

Pharmaceutical Contract Sales Organization (CSO) Segment by Type

Personal Promotion

Non-Personal Promotion

Others

Pharmaceutical Contract Sales Organization (CSO) Segment by Application

Pharmaceutical Company

Biotechnology Company

Generic Company

Others

Pharmaceutical Contract Sales Organization (CSO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Contract Sales Organization (CSO) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Contract Sales Organization (CSO) key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Contract Sales Organization (CSO) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Contract Sales Organization (CSO) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Contract Sales Organization (CSO) significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Contract Sales Organization (CSO) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Sales Organization (CSO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Sales Organization (CSO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Sales Organization (CSO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Contract Sales Organization (CSO) industry.

Chapter 3: Detailed analysis of Pharmaceutical Contract Sales Organization (CSO) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Contract Sales Organization (CSO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Contract Sales Organization (CSO) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Contract Sales Organization (CSO) Industry Trends Table 2. Pharmaceutical Contract Sales Organization (CSO) Industry Drivers Table 3. Pharmaceutical Contract Sales Organization (CSO) Industry Opportunities and Challenges Table 4. Pharmaceutical Contract Sales Organization (CSO) Industry Restraints Table 5. Global Pharmaceutical Contract Sales Organization (CSO) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Contract Sales Organization (CSO) Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Contract Sales Organization (CSO) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Contract Sales Organization (CSO) Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Contract Sales Organization (CSO) Company, Product Type & Application Table 10. Global Pharmaceutical Contract Sales Organization (CSO) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Contract Sales Organization (CSO) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Personal Promotion Table 15. Significant Companies of Non-Personal Promotion Table 16. Significant Companies of Others Table 17. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type (2021-2026) Table 21. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Pharmaceutical Company Table 23. Significant Companies of Biotechnology Company Table 24. Significant Companies of Generic Company Table 25. Significant Companies of Others Table 26. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application (2021-2026) Table 30. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application (2027-2032) Table 31. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Region (2021-2026) Table 34. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Region (2027-2032) Table 36. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Market Share by Country (2021-2026) Table 39. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Market Share by Country (2027-2032) Table 41. China Medical System (CMS) Company Information Table 42. China Medical System (CMS) Business Overview Table 43. China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 45. China Medical System (CMS) Recent Development Table 46. IQVIA Company Information Table 47. IQVIA Business Overview Table 48. IQVIA Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. IQVIA Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 50. IQVIA Recent Development Table 51. PHOENIX Group Company Information Table 52. PHOENIX Group Business Overview Table 53. PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 55. PHOENIX Group Recent Development Table 56. EVERSANA Company Information Table 57. EVERSANA Business Overview Table 58. EVERSANA Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. EVERSANA Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 60. EVERSANA Recent Development Table 61. Ashfield Engage (Inizio) Company Information Table 62. Ashfield Engage (Inizio) Business Overview Table 63. Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 65. Ashfield Engage (Inizio) Recent Development Table 66. Amplity Health Company Information Table 67. Amplity Health Business Overview Table 68. Amplity Health Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Amplity Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 70. Amplity Health Recent Development Table 71. Sinco Pharma Company Information Table 72. Sinco Pharma Business Overview Table 73. Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 75. Sinco Pharma Recent Development Table 76. Syneos Health Company Information Table 77. Syneos Health Business Overview Table 78. Syneos Health Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Syneos Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 80. Syneos Health Recent Development Table 81. EPS Corporation Company Information Table 82. EPS Corporation Business Overview Table 83. EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 85. EPS Corporation Recent Development Table 86. Uniphar Group Company Information Table 87. Uniphar Group Business Overview Table 88. Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 90. Uniphar Group Recent Development Table 91. CMIC Group Company Information Table 92. CMIC Group Business Overview Table 93. CMIC Group Pharmaceutical Contract Sales Organization (CSO) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. CMIC Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 95. CMIC Group Recent Development Table 96. SciClone Pharmaceuticals Company Information Table 97. SciClone Pharmaceuticals Business Overview Table 98. SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 100. SciClone Pharmaceuticals Recent Development Table 101. China Pioneer Pharma Company Information Table 102. China Pioneer Pharma Business Overview Table 103. China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 105. China Pioneer Pharma Recent Development Table 106. Promoveo Health Company Information Table 107. Promoveo Health Business Overview Table 108. Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 110. Promoveo Health Recent Development Table 111. CSO Pharmitalia Company Information Table 112. CSO Pharmitalia Business Overview Table 113. CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 115. CSO Pharmitalia Recent Development Table 116. GTS Solution Company Information Table 117. GTS Solution Business Overview Table 118. GTS Solution Pharmaceutical Contract Sales Organization (CSO) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. GTS Solution Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 120. GTS Solution Recent Development Table 121. QFR Solutions Company Information Table 122. QFR Solutions Business Overview Table 123. QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 125. QFR Solutions Recent Development Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Pharmaceutical Contract Sales Organization (CSO) Product Image Figure 2. Global Pharmaceutical Contract Sales Organization (CSO) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Contract Sales Organization (CSO) Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Contract Sales Organization (CSO) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Personal Promotion Image Figure 8. Non-Personal Promotion Image Figure 9. Others Image Figure 10. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type (2021-2032) Figure 13. Pharmaceutical Company Image Figure 14. Biotechnology Company Image Figure 15. Generic Company Image Figure 16. Others Image Figure 17. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application (2021-2032) Figure 20. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pharmaceutical Contract Sales Organization (CSO) Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pharmaceutical Contract Sales Organization (CSO) Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pharmaceutical Contract Sales Organization (CSO) Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Personal Promotion
  • Non-Personal Promotion
  • Others
Applications
  • Pharmaceutical Company
  • Biotechnology Company
  • Generic Company
  • Others
Companies covered
  • China Medical System (CMS)
  • IQVIA
  • PHOENIX Group
  • EVERSANA
  • Ashfield Engage (Inizio)
  • Amplity Health
  • Sinco Pharma
  • Syneos Health
  • EPS Corporation
  • Uniphar Group
  • CMIC Group
  • SciClone Pharmaceuticals
  • China Pioneer Pharma
  • Promoveo Health
  • CSO Pharmitalia
  • GTS Solution
  • QFR Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Contract Sales Organization (CSO) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Contract Sales Organization (CSO) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Contract Sales Organization (CSO) Market Dynamics
  1. 2.1 Pharmaceutical Contract Sales Organization (CSO) Industry Trends
  2. 2.2 Pharmaceutical Contract Sales Organization (CSO) Industry Drivers
  3. 2.3 Pharmaceutical Contract Sales Organization (CSO) Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Contract Sales Organization (CSO) Industry Restraints
3 Pharmaceutical Contract Sales Organization (CSO) Market by Company
  1. 3.1 Global Pharmaceutical Contract Sales Organization (CSO) Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Contract Sales Organization (CSO) Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Contract Sales Organization (CSO) Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Contract Sales Organization (CSO) Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Contract Sales Organization (CSO) Company Product Type and Application
  6. 3.6 Global Pharmaceutical Contract Sales Organization (CSO) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Contract Sales Organization (CSO) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Contract Sales Organization (CSO) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Contract Sales Organization (CSO) Market by Type
  1. 4.1 Pharmaceutical Contract Sales Organization (CSO) Type Introduction
  2. 4.1.1 Personal Promotion
  3. 4.1.2 Non-Personal Promotion
  4. 4.1.3 Others
  5. 4.2 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Type
  6. 4.2.1 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Type (2021-2032)
  8. 4.2.3 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type (2021-2032)
5 Pharmaceutical Contract Sales Organization (CSO) Market by Application
  1. 5.1 Pharmaceutical Contract Sales Organization (CSO) Application Introduction
  2. 5.1.1 Pharmaceutical Company
  3. 5.1.2 Biotechnology Company
  4. 5.1.3 Generic Company
  5. 5.1.4 Others
  6. 5.2 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Application
  7. 5.2.1 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Application (2021-2032)
  9. 5.2.3 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application (2021-2032)
6 Pharmaceutical Contract Sales Organization (CSO) Regional Value Analysis
  1. 6.1 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Contract Sales Organization (CSO) Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Contract Sales Organization (CSO) Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Contract Sales Organization (CSO) Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Contract Sales Organization (CSO) Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Contract Sales Organization (CSO) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Contract Sales Organization (CSO) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Contract Sales Organization (CSO) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 China Medical System (CMS)
  2. 8.1.1 China Medical System (CMS) Company Information
  3. 8.1.2 China Medical System (CMS) Business Overview
  4. 8.1.3 China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  6. 8.1.5 China Medical System (CMS) Recent Developments
  7. 8.2 IQVIA
  8. 8.2.1 IQVIA Company Information
  9. 8.2.2 IQVIA Business Overview
  10. 8.2.3 IQVIA Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IQVIA Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  12. 8.2.5 IQVIA Recent Developments
  13. 8.3 PHOENIX Group
  14. 8.3.1 PHOENIX Group Company Information
  15. 8.3.2 PHOENIX Group Business Overview
  16. 8.3.3 PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  18. 8.3.5 PHOENIX Group Recent Developments
  19. 8.4 EVERSANA
  20. 8.4.1 EVERSANA Company Information
  21. 8.4.2 EVERSANA Business Overview
  22. 8.4.3 EVERSANA Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 EVERSANA Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  24. 8.4.5 EVERSANA Recent Developments
  25. 8.5 Ashfield Engage (Inizio)
  26. 8.5.1 Ashfield Engage (Inizio) Company Information
  27. 8.5.2 Ashfield Engage (Inizio) Business Overview
  28. 8.5.3 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  30. 8.5.5 Ashfield Engage (Inizio) Recent Developments
  31. 8.6 Amplity Health
  32. 8.6.1 Amplity Health Company Information
  33. 8.6.2 Amplity Health Business Overview
  34. 8.6.3 Amplity Health Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Amplity Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  36. 8.6.5 Amplity Health Recent Developments
  37. 8.7 Sinco Pharma
  38. 8.7.1 Sinco Pharma Company Information
  39. 8.7.2 Sinco Pharma Business Overview
  40. 8.7.3 Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  42. 8.7.5 Sinco Pharma Recent Developments
  43. 8.8 Syneos Health
  44. 8.8.1 Syneos Health Company Information
  45. 8.8.2 Syneos Health Business Overview
  46. 8.8.3 Syneos Health Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Syneos Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  48. 8.8.5 Syneos Health Recent Developments
  49. 8.9 EPS Corporation
  50. 8.9.1 EPS Corporation Company Information
  51. 8.9.2 EPS Corporation Business Overview
  52. 8.9.3 EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  54. 8.9.5 EPS Corporation Recent Developments
  55. 8.10 Uniphar Group
  56. 8.10.1 Uniphar Group Company Information
  57. 8.10.2 Uniphar Group Business Overview
  58. 8.10.3 Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  60. 8.10.5 Uniphar Group Recent Developments
  61. 8.11 CMIC Group
  62. 8.11.1 CMIC Group Company Information
  63. 8.11.2 CMIC Group Business Overview
  64. 8.11.3 CMIC Group Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CMIC Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  66. 8.11.5 CMIC Group Recent Developments
  67. 8.12 SciClone Pharmaceuticals
  68. 8.12.1 SciClone Pharmaceuticals Company Information
  69. 8.12.2 SciClone Pharmaceuticals Business Overview
  70. 8.12.3 SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  72. 8.12.5 SciClone Pharmaceuticals Recent Developments
  73. 8.13 China Pioneer Pharma
  74. 8.13.1 China Pioneer Pharma Company Information
  75. 8.13.2 China Pioneer Pharma Business Overview
  76. 8.13.3 China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  77. 8.13.4 China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  78. 8.13.5 China Pioneer Pharma Recent Developments
  79. 8.14 Promoveo Health
  80. 8.14.1 Promoveo Health Company Information
  81. 8.14.2 Promoveo Health Business Overview
  82. 8.14.3 Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  84. 8.14.5 Promoveo Health Recent Developments
  85. 8.15 CSO Pharmitalia
  86. 8.15.1 CSO Pharmitalia Company Information
  87. 8.15.2 CSO Pharmitalia Business Overview
  88. 8.15.3 CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  90. 8.15.5 CSO Pharmitalia Recent Developments
  91. 8.16 GTS Solution
  92. 8.16.1 GTS Solution Company Information
  93. 8.16.2 GTS Solution Business Overview
  94. 8.16.3 GTS Solution Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  95. 8.16.4 GTS Solution Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  96. 8.16.5 GTS Solution Recent Developments
  97. 8.17 QFR Solutions
  98. 8.17.1 QFR Solutions Company Information
  99. 8.17.2 QFR Solutions Business Overview
  100. 8.17.3 QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Revenue and Gross Margin (2021-2026)
  101. 8.17.4 QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  102. 8.17.5 QFR Solutions Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst